China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA)

Aug, 2017   |   105  Pages   |   Renub Research   |   Format : PDF
China molecular diagnostics market is growing at a fast pace owing to rising prevalence of infectious diseases and cancer cases in the region coupled with growing geriatric population. It is projected that China molecular diagnostics market will exceed US$ 1.5 Billion by the end of 2022. Molecular diagnostics are extremely effective in diagnosing and preventing diseases, offering accurate and precise healthcare interventions in the early stages of diseases.

China Molecular Diagnostics Segments Market

China molecular diagnostics market has been segmented into three major categories: Oncology Testing, Infectious Disease Testing and Genetic Disease Testing. Further, Oncology Testing has been segmented into three major categories: Breast Cancer Testing, Colorectal Cancer Testing and Prostate Cancer Testing. Infectious Disease Testing has been segmented into two major categories, namely, virology and HPV and Genetic Testing has been segmented into Blood Screening and HLA.

China Infectious Disease test market; Virology tests accounts for the highest market share. Furthermore, our analysis found that nearly 300 million molecular diagnostic tests will be performed in China by the end of 2022 of which Virology accounts for one of the most performed tests segments.

Increasing incidence of contagious diseases along with cancer cases and the rise of the private healthcare sector in China, with the development of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region are some of the contributors which are anticipated to drive the molecular diagnostics market over the forecast period.

This is the 5th report on Molecular Diagnostics industry published by Renub Research. This report titled “China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA)” provides a comprehensive assessment of the fast–evolving, high–growth China Molecular diagnostics market. This 105 page report with 55 Figures and 14 Tables studies the China Molecular Diagnostic market from 4 view points:

1. Market & Forecast
2. Molecular Diagnostics Segments Market & Forecast
3. Molecular Diagnostics Segments Test Volume & Forecast
4. Profiles of Select Private Clinical Labs & Diagnostic Services Companies
 
Segments Covered in this report are as follows:

Oncology Test Market and Volume

• Breast Cancer
• Colorectal Cancer
• Prostate Cancer

Infectious Disease Test Market and Volume

• Virology
• HPV

Genetic Test Market and Volume

• Blood Screening
• HLA

Key Players Analysis

• Zhejiang Di’an Diagnostics Technology Co., Ltd.
• ADICON Clinical Laboratories (Privately held)
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global (Privately held)
• BGI–Shenzhen
• OriGene Technologies   

Key questions answered in the study

•  What is China molecular diagnostics market size from 2011 to 2022?
•  What is China molecular diagnostics tests volume from 2011 to 2022?
•  What are China molecular diagnostics segments market & Forecast?
•  What are the growth drivers of Molecular diagnostics in China?
1. Research Findings

2. China Molecular Diagnostic Market & Test Volume Forecast
2.1 China Molecular Diagnostic Market

2.2 China Molecular Diagnostic Test Volume

3. China Molecular Diagnostic Market Share Analysis
3.1 Market Share – (Oncology, Infectious, Genetic) Testing

3.2 Market Share – Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

4. China Molecular Diagnostic Volume Share (2011 – 2022)
4.1 Volume Share – (Oncology, Infectious, Genetic) Testing

4.2 Volume Share – Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

5. Segments Test Volume – China Molecular Diagnostics
5.1 Volume Share – (Breast, Colorectal, Prostate) Oncology Test

5.2 Oncology Test Volume
5.2.1 Breast Cancer Test Volume
5.2.2 Colorectal Cancer Test Volume
5.2.3 Prostate Cancer Test Volume

5.3 Volume Share – (Virology, HPV) Infectious Disease Test

5.4 Infectious Disease Test Volume
5.4.1 Virology Test Volume
5.4.2 HPV Test Volume

5.5 Volume Share – (Blood Screening, HLA) Genetic Test

5.6 Genetic Test Volume
5.6.1 Blood Screening Test Volume
5.6.2 HLA Test Volume

6. Segments Test Market – China Molecular Diagnostics Market (2011 – 2022)
6.1 Market Share – (Breast, Colorectal, Prostate) Oncology Test

6.2 Oncology Test Market
6.2.1 Breast Cancer Test Market
6.2.2 Colorectal Cancer Test Market
6.2.3 Prostate Cancer Test Market

6.3 Market Share – (Virology, HPV) Infectious Disease Test

6.4 Infectious Disease Test Market
6.4.1 Virology Test Market
6.4.2 HPV Test Market

6.5 Market Share – (Blood Screening, HLA) Genetic Test

6.6 Genetic Test Market
6.6.1 Blood Screening Market
6.6.2 HLA Test Market

7. China Healthcare Insurance Schemes
7.1 China Healthcare Insurance Schemes
7.1.1 NRCMS
7.1.2 UEBMI
7.1.3 URBMI
7.1.4 Private Health Insurance
7.1.5 Cost-sharing and out-of-pocket Spending

8. Growth Drivers
8.1 Rising Order for High Quality Healthcare Products

8.2 Growing Cases of Lifestyle Diseases

8.3 Rapid Diagnosis of Infectious Diseases

8.4 Rise in Number of Private Hospitals & Independent Diagnostics Clinics
8.4.1 Rise in the Number of Hospital Beds across all Medical Institutions

8.5 Increasing Automation

9. Challenges
9.1 Nil Government Support & Public Awareness

9.2 Dearth of Trained Medical Technicians

9.3 Reimbursement Rates differ from Province to Province in China
9.3.1 Chinese Government Regulating Laboratory Testing in China

10. Profiles of Select Private Clinical Labs and Diagnostic Services Companies
10.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.
10.1.1 Company Overview
10.1.2 Products and Services Offered by Di’an

10.2 ADICON Clinical Laboratories (Privately held)
10.2.1 Company Overview
10.2.2 Products and Services Offered by ADICON

10.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
10.3.1 Company Overview
10.3.2 Products and Services Offered by Kingmed

10.4 Kindstar Global (Privately held)
10.4.1 Company Overview
10.4.2 Products and Services Offered by Kindstar

10.5 BGI–Shenzhen
10.5.1 Company Overview
10.5.2 BGI’s Innovative Approach

10.6 OriGene Technologies
10.6.1 Company Overview
10.6.2 Products and Services Offered by OriGene

List of Figures

Figure 2–1: China – Molecular Diagnostic Market (Million US$), 2011 – 2016
Figure 2–2: China – Forecast for Molecular Diagnostic Market (Million US$), 2017 – 2022
Figure 2–3: China – Molecular Diagnostic Test Volume (Million), 2011 – 2016
Figure 2–4: China – Forecast for Molecular Diagnostic Test Volume (Million), 2017 – 2022

Figure 3–1: China – Molecular Diagnostic Market Share (Percent), 2011 – 2016
Figure 3–2: China – Forecast for Molecular Diagnostic Market Share (Percent), 2017 – 2022
Figure 3–5: China – Molecular Diagnostic Test Volume Share (Percent), 2011 – 2016
Figure 3–6: China – Forecast for Molecular Diagnostic Test Volume Share (Percent), 2017 – 2022

Figure 4–1: China – Molecular Oncology Test Volume Share (Percent), 2011 – 2016
Figure 4–2: China – Forecast for Molecular Oncology Test Volume Share (Percent), 2017 – 2022
Figure 4–3: Rural China – Cancer Screening Sites by Cancer Type (Number), 2013
Figure 4–4: China – Oncology Test Volume (Million), 2011 – 2016
Figure 4–5: China – Forecast for Oncology Test Volume (Million), 2017 – 2022
Figure 4–6: China –Breast Cancer Molecular Test Volume (Million), 2011 – 2016
Figure 4–7: China – Forecast for Breast Cancer Molecular Test Volume (Million), 2017 – 2022
Figure 4–8: China –Colorectal Cancer Test Volume (Million), 2011 – 2016
Figure 4–9: China – Forecast for Colorectal Cancer Test Volume (Million), 2017 – 2022
Figure 4–10: China –Prostate Cancer Test Volume (Million), 2011 – 2016
Figure 4–11: China – Forecast for Prostate Cancer Test Volume (Million), 2017 – 2022
Figure 4–14: China –Infectious Disease Test Volume (Million), 2011 – 2016
Figure 4–15: China – Forecast for Infectious Disease Test Volume (Million), 2017 – 2022
Figure 4–16: China –Virology Test Volume (Million), 2011 – 2016
Figure 4–17: China – Forecast for Virology Test Volume (Million), 2017 – 2022
Figure 4–18: China –HPV Test Volume (Thousand), 2011 – 2016
Figure 4–19: China – Forecast for HPV Test Volume (Thousand), 2017 – 2022
Figure 4–22: China –Genetic Test Volume (Million), 2011 – 2016
Figure 4–23: China – Forecast for Genetic Test Volume (Million), 2017 – 2022
Figure 4–24: China –Blood Screening Test Volume (Million), 2011 – 2016
Figure 4–25: China – Forecast for Blood Screening Test Volume (Million), 2017 – 2022
Figure 4–26: China – HLA Test Volume (Thousand), 2011 – 2016
Figure 4–27: China – Forecast for HLA Test Volume (Thousand), 2017 – 2022

Figure 5–1: China – Molecular Oncology Test Market Share (Percent), 2011 – 2016
Figure 5–2: China – Forecast for Molecular Oncology Test Market Share (Percent), 2017 – 2022
Figure 5–3: China –Oncology Test Market (Million US$), 2011 – 2016
Figure 5–4: China – Forecast for Oncology Test Market (Million US$), 2017 – 2022
Figure 5–5: China –Breast Cancer Test Market (Million US$), 2011 – 2016
Figure 5–6: China – Forecast for Breast Cancer Test Market (Million US$), 2017 – 2022
Figure 5–7: China –Colorectal Cancer Test Market (Million US$), 2011 – 2016
Figure 5–8: China – Forecast for Colorectal Cancer Test Market (Million US$), 2017 – 2022
Figure 5–9: China –Prostate Cancer Testing Market (Million US$), 2011 – 2016
Figure 5–10: China – Forecast for Prostate Cancer Testing Market (Million US$), 2017 – 2022
Figure 5–13: China –Infectious Disease Test Market (Million US$), 2011 – 2016
Figure 5–14: China – Forecast for Infectious Disease Test Market (Million US$), 2017 – 2022
Figure 5–15: China –Virology Test Market (Million US$), 2011 – 2016
Figure 5–16: China – Forecast for Virology Test Market (Million US$), 2017 – 2022
Figure 5–17: China –HPV Test Market (Million US$), 2011 – 2016
Figure 5–18: China – Forecast for HPV Test Market (Million US$), 2017 – 2022
Figure 5–21: China –Genetic Testing Market (Million US$), 2011 – 2016
Figure 5–22: China – Forecast for Genetic Testing Market (Million US$), 2017 – 2022
Figure 5–23: China –Blood Screening Market (Million US$), 2011 – 2016
Figure 5–24: China – Forecast for Blood Screening Market (Million US$), 2017 – 2022
Figure 5–25: China – HLA Test Market (Thousand US$), 2011 – 2016
Figure 5–26: China – Forecast for HLA Test Market (Thousand US$), 2017 – 2022

Figure 6–1: China – Healthcare Spending (Billion US$), 2011 &2020

Figure 8–1: Kindstar – Collaboration with Hospitals in China (Number), 2006–2012

List of Tables

Table 3–1: China – Molecular Diagnostic Application Market Share (Percent), 2011 – 2016
Table 3–2: China – Forecast for Molecular Diagnostic Application Market Share (Percent), 2017 – 2022
Table 3–3: China – Molecular Diagnostic Test Volume Application Share (Percent), 2011 – 2016
Table 3–4: China – Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2017 – 2022

Table 4–1: China – Molecular Infectious Disease Test Volume Share (Percent), 2011 – 2016
Table 4–2: China – Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2017 – 2022
Table 4–3: China – Molecular Genetic Test Volume Share (Percent), 2011 – 2016
Table 4–4: China – Forecast for Molecular Genetic Test Volume Share (Percent), 2017 – 2022

Table 5–1: China – Molecular Infectious Disease Test Market Share (Percent), 2011 – 2016
Table 5–2: China – Forecast for Molecular Infectious Disease Test Market Share (Percent), 2017 – 2022
Table 5–3: China – Molecular Genetic Test Market Share (Percent), 2011 – 2016
Table 5–4: China – Forecast for Molecular Genetic Test Market Share (Percent), 2017 – 2022

Table 6–1: China – Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010

Table 8‑1: Number of Hospital Beds for every 1,000 people
China Petrochemicals Report
The China Petrochemicals Report has been researched at source, and features BMI Research's market assessment and independent forecasts for key petrochemicals sub-sectors. The report also analyses the impact of regulatory changes, recent developments and the background macroeconomic outlook and featu
China Oil and Gas Report
BMI View: China's long-term crude oil and liquids output will remain on a firm downtrend as low oil prices slowdown exploration and render certain high-cost mature and unconventional plays uneconomic. Outlook is more positive for natural gas, as the government seeks to increase the share of ga
China Pharmaceuticals and Healthcare Report
BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments 'in China, for China'. The local industry, while stil
China Telecommunications Report
BMI View: Operator strategies will continue to chime with the government's directive to drive uptake of wireline broadband and machine-to-machine (M2M) connections. However, this means that even as subscription numbers rise, the prices of basic services will be compressed and operators will derive p
Global and China Lithium Carbonate Industry Report, 2016-2020
Driven by a surge in sales volume of new energy vehicles in China, the upstream material- lithium carbonate was in short supply in the fourth quarter of 2015 with soaring prices. Global lithium carbonate output increased by 12.3% year on year to 202,800 tons in 2015 and is expected to arrive at 244,

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonchina.com
Fax Number: +91 22 27812707

Follow Us On: